image: Join the speakers at Targeting Microbiota 2024 in Malta this October to learn more about the translation of microbiome research into clinical breakthroughs
Credit: International Society of Microbiota
The 11th Annual ISM Congress on Targeting Microbiota, taking place on October 14-15, 2024, in Malta, will convene leading experts to examine the emerging role of the gut microbiome in systemic health. This year's congress will spotlight advanced research elucidating how the gut microbiome modulates critical physiological processes, impacting conditions such as obesity, diabetes, irritable bowel syndrome (IBS), depression and metabolic disorders. Key presentations will explore the mechanisms by which microbial metabolites exert systemic effects, the identification of specific gut microbiome signatures linked to chronic diseases, and the potential of precision nutrition interventions based on individual microbiome profiles.
Translating Microbiome Research into Clinical Breakthroughs
The congress aims to bridge the gap between research and clinical practice, emphasizing the gut microbiome as a central determinant of systemic health and a promising target for novel therapeutic strategies. Attendees will engage with the latest scientific insights on microbiome modulation, exploring how these findings can be leveraged to advance the treatment and prevention of chronic diseases, marking a pivotal shift in the future of medicine.
Outstanding Speakers & Topics
Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia (Keynote Speaker Day 1) – Phage Therapy: A New Era of “Old” Concept for “Microbiome” Health
Marvin Edeas, Institut Cochin, INSERM U1016, Université de Paris, France (Keynote Speaker Day 2) – The Mystery of the Microbiome Genome: The Potential of 2 to 20 Million Microbial Genes to Transform Our Health
Martin Loessner, ETH Zurich, Switzerland – Bacteriophages Redesigned – Tiny Killers and Detectives to Support Infectious Disease Therapy
Alan Walker, University of Aberdeen, United Kingdom – Mythbusting Our Microbiome
Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan – Gut Microbiome, Obesity and Diabetes
Patrick C. H. Hsieh, Academia Sinica, Tawian – Gut Bacteria and Heart Healing: The Hidden Players in Post-Infarction Resilience
Simone Domenico Guglielmetti, Università degli Studi di Milano-Bicocca, Italy – Gut Microbiome Signatures in Irritable Bowel Syndrome
Justus Reunanen, University of Oulu, Finland – Microbiota-Derived Extracellular Vesicles: Bridging Mother and Fetus
Souhaila Al Khodor, Sidra Medicine, Qatar – Deciphering the role of the Oral-Placental and Vaginal-Placental Microbiome Axes in Preterm Birth
Markus Egert, Furtwangen University, Germany – Using Roseoflavin, a Natural Riboflavin Analogue, to Modify the Human Microbiota
Koen Venema, Editor-in-chief of Beneficial Microbes, Netherlands – Sophisticated in vitro Models of the Gastrointestinal Tract to Study the Role of the Gut Microbiota in Health and Disease
Christian Riedel, University of Ulm, Germany – From Microbiomes and (Meta)genomes to the Lab and Back - Identification, Production and Application of Bacteriocins
Andreas Schwiertz, Institute of Microecology, Germany – Probiotics & Health: How to Select the Right Strain?
Rochellys Diaz Heijtz, Karolinska Institutet, Sweden – Gut Microbiota in Early Life: Impact on Neurodevelopmental Outcomes
José Manuel Fernández-Real, Institut d'Investigació Biomèdica de Girona, Hospital Trueta de Girona, and University of Girona, Spain – Gut Brain Axis & Depression: Startegic Role of Dietary Proline Exposed
Ellen Blaak, Maastricht University, Netherlands – Microbial Phenotypes in Obesity: Implications for Precision Nutrition
Pascale Vonaesch, University of Lausanne, Switzerland – The Small Intestinal Microbiota: A Hidden Player in Human Health and Disease
Bina Joe, University of Toledo, USA – Prospects for Leveraging the Microbiota as Medicine for Hypertension
Cristian O'Flaherty, McGill University, Canada – Male Fertility and Gut Microbiota: Current Knowledge and Future Directions
Congress supporter: DNA Genotek.
For more information about the meeting speakers, attendees, and scientific content, please visit: www.microbiota-ism.com.
About the International Society of Microbiota (ISM)
The ISM was established in 2013, evolving from the Task Force Mitochondria-Microbiota to encompass experts in the field of microbiota. The ISM aims to accelerate the credible translation of microbiota science into real benefits for consumers. It also encourages communication and interaction among researchers, physicians, nutritionists, industry professionals, and strategic marketing managers through a global microbiota network, particularly during its annual world meeting.